Carlos Casasnovas

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial.

Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial.

Journal: JAMA neurology

Published: July 27, 2026

Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder.

Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder.

Journal: American journal of human genetics

Published: April 05, 2026

Model-guided medicine for early diagnosis of transthyretin-associated cardiac amyloidosis using multimodal data integration and standardized interoperable models (the CRONOS-ATTR study).

Model-guided medicine for early diagnosis of transthyretin-associated cardiac amyloidosis using multimodal data integration and standardized interoperable models (the CRONOS-ATTR study).

Journal: International journal of computer assisted radiology and surgery

Published: October 27, 2025

Efficacy and safety of patisiran for the treatment of acquired amyloid polyneuropathy in domino liver transplant recipients.

Efficacy and safety of patisiran for the treatment of acquired amyloid polyneuropathy in domino liver transplant recipients.

Journal: Therapeutic advances in neurological disorders

Published: June 23, 2025

Dynamics of Nerve Conduction Studies in Patients With Guillain-Barré Syndrome.

Dynamics of Nerve Conduction Studies in Patients With Guillain-Barré Syndrome.

Journal: Muscle & nerve

Published: June 10, 2025

Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome.

Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome.

Journal: Brain : a journal of neurology

Published: November 08, 2024

Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain.

Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain.

Journal: Revista espanola de cardiologia (English ed.)

Published: September 24, 2024

The Results of ADVANCE-CIDP IVIG Trial: Intravenous Immunoglobulin 10% Therapy With GAMMAGARD LIQUID/Kiovig for Treatment of Relapse in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

The Results of ADVANCE-CIDP IVIG Trial: Intravenous Immunoglobulin 10% Therapy With GAMMAGARD LIQUID/Kiovig for Treatment of Relapse in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Journal: European journal of neurology

Published: August 16, 2024

Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder.

Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder.

Journal: American journal of human genetics

Published: July 31, 2024

Epilepsy and Myasthenia Gravis: A Case Series.

Epilepsy and Myasthenia Gravis: A Case Series.

Journal: Brain sciences

Published: July 26, 2024

Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.

Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.

Journal: Frontiers in pharmacology

Published: April 20, 2024

Safety, Tolerability, and Outcomes of Tafamidis for the Treatment of Acquired Amyloid Neuropathy in Domino Liver Transplant Recipients.

Safety, Tolerability, and Outcomes of Tafamidis for the Treatment of Acquired Amyloid Neuropathy in Domino Liver Transplant Recipients.

Journal: Neurology and therapy

Published: March 03, 2024

Showing 1-12 of 79

Last Updated: 09/26/2026